Vancomycin serum concentration monitoring: a continued debate.
Pryka
R D
RD
D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000009:adverse effects; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000628:therapy; D016365:Liability, Legal; D006435:Renal Dialysis; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood*
D014640:Vancomycin